Prostate specific antigen outcome based on the extent of extracapsular extension and margin status in patients with seminal vesicle negative prostate carcinoma of gleason score ≤ 7

Cancer

Volumn 88, Issue 9, 2000, Pages 2110-2115

  D'Amico, Anthony V ^a   Whittington, Richard ^b   Malkowicz, S Bruce ^b   Schultz, Delray ^c   Tomaszewski, John E ^b   Wein, Alan ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c University of Millersville   (United States)

Author keywords

Extracapsular extension; Gleason score; Margin status; Outcome; Prostate carcinoma; Prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; PROSTATECTOMY; SEMINAL VESICLE; TREATMENT OUTCOME;

ACTUARIAL ANALYSIS; CARCINOMA; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; FORECASTING; HUMANS; LYMPH NODE EXCISION; MALE; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; SEMINAL VESICLES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0034192168     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000501)88:9<2110::AID-CNCR17>3.0.CO;2-E     Document Type: Article

References (17)

1. Zincke H, Bergstralh KJ, Blute ML, Myers RP, Barrett DM, Lieber MM, et al. Radical prostatectomy for clinically localized prostate cancer: long-term results of 1,143 patients from a single institution. J Clin Oncol 1994;12:2254-61.
2. Kupelian P, Katcher J, Levin HS, Klein EA. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy. Int J Radiat Oncol Biol Phys 1997;37:1043-52.
3. Walsh PC, Partin AW, Epstein JI. Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol 1994;152:1831-6.
4. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999;281: 1591-7.
5. D'Amico AV, Whittington R, Malkowicz SB, Fondurulia I, Chen MU, Tomaszewski JF, et al. The combination of the preoperative prostate-specific antigen level and postoperative pathologic findings to predict PSA outcome in men with clinically localized prostate cancer. J Urol 1998;30:293-302.
6. Epstein JI, Pizov G, Walsh PC. Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer 1993;71:3582-9.
7. Beahrs OH, Henson DE, Hutter RW. American Joint Committee on Cancer Manual for Staging Cancer. 4th ed. Philadelphia: JB Lippincott, 1997.
8. Gleason DF, Veterans Administration Cooperative Urological Research Group. Histologic grading and staging of prostatic carcinoma. In: Tannenbaum M, editor. Urologic pathology. Philadelphia: Lea and Febiger; 1977:171-87.
9. Oesterling JE, Jacobsen SJ, Klee GG, Pettersson K, Pironen T, Abrahamsson P, et al. Free, complexed and total serum prostate specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios. J Urol 1995;154:1090-5.
10. Simultaneous inferences and other topics in regression analysis-1. In: Neter J, Wasserman W, Kutner M, editors. Applied linear regression models, 1st ed. Homewood, IL: Richard D. Irwin, Inc., 1983:150-3.
11. Kaplan FL, Meier P. Non-parametric estimation from incomplete observations. J Amer Stat Assoc 1958;53:457-500.
12. Stamey TA, McNeal JK, Yemoto CM, Sigal BM, Johnstone IM. Biological determinants of cancer in men with prostate cancer. JAMA 1999;281:1395-1400.
13. Cadeddu JA, Partin AW, Deweese TL, Walsh PC. Long term results of radiation therapy for prostate cancer recurrence following radical prostatectomy. J Urol 1998;159:173-8.
14. Morris MM, Dallow KC, Zietman AL, Park I, Althausen A, Heney NH, et al. Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys 1997;38:731-6.
15. Forman JD, Velasco J. Therapeutic radiation in patients with a rising post-prostatectomy PSA level. Oncology 1998;12:33-47.
16. Do T, Parker RG, Do C, Tran L, Do L, Dolkar D. Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy. Cancer J Sci Am 1998;4:324-30.
17. Schild SF, Buskirk SJ, Wong WW, Halyard MY, Swanson SK, Novicki DE, et al. The use of radiotherapy for patients with isolated elevation of serum prostate-specific antigen following radical prostatectomy. J Urol 1996;156:1725-9.